Phase 3 study of AMR101 for the treatment of high triglycerides - MPR
Links shared publicly online about this topic.
- 1,464total visits
Phase 3 study of AMR101 for the treatment of high triglycerides - MPR
empr.com —
View full resource at empr.com
Tags: Phase 3 Clinical Trial, News
Most Recently Shared on January 11, 2010 at 5:01 pm By:
MPR News: Phase 3 study of AMR101 for the treatment of high triglycerides: Amarin Corporation announced the enroll... http://bit.ly/4Fss8g
Phase 3 Study of AMR101 for Hypertriglyceridemia - ONA
oncologynurseadvisor.com — “Amarin Corporation announced positive results from its Phase 3 study of AMR101 for the treatment of patients with high triglycerides (TG) without increasing LDL-C levels in patients on background statin therapy.” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 18, 2011 at 2:34 pm By:
OncologyNurseAdvisor Nursing, Medical Education, Medical Publisher, and Oncology
Phase 3 Study of AMR101 for Hypertriglyceridemia http://goo.gl/fb/8o86e
Phase 3 study of AMR101 for the treatment of hypertriglyceridemia - ONA
oncologynurseadvisor.com — “Amarin announced positive results from its Phase 3 study of AMR101 for the treatment of very high triglyceride levels or hypertriglyceridemia.” View full resource at oncologynurseadvisor.com
Most Recently Shared on November 30, 2010 at 10:02 pm By:
OncologyNurseAdvisor Nursing, Medical Education, Medical Publisher, and Oncology
Phase 3 study of AMR101 for the treatment of hypertriglyceridemia http://goo.gl/fb/whFAE
Essentialis, FDA enter agreement on SPA for DCCR Phase 3 efficacy study in patients with high triglycerides
news-medical.net — “Essentialis, Inc. announced today that the company has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for a Phase 3 efficacy study required for product registration for its product candidate, Diazoxide Choline Controlled Release Tablet (DCCR), for the treatment of patients with very high triglycerides.” View full resource at news-medical.net
Most Recently Shared on October 25, 2010 at 11:37 am By:
Essentialis, FDA enter agreement on SPA for DCCR Phase 3 efficacy study in patients with high triglycerides: Essen... http://bit.ly/dCs6HA
Amarin commences enrollment in its AMR101 Phase 3 clinical trials for cardiovascular disease
news-medical.net — “Amarin Corporation plc, a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease, today announced that first patients were enrolled in the MARINE and ANCHOR Phase 3 clinical trials for AMR101, the Company's lead product candidate. These clinical trials are designed to demonstrate that AMR101 lowers triglyceride levels in patients with very high triglycerides (the MARINE Study) and high triglycerides in patients with mixed dyslipidemia being treated ” View full resource at news-medical.net
Most Recently Shared on January 12, 2010 at 8:57 am By:
Obesity News: Amarin commences enrollment in its AMR101 Phase 3 clinical trials for cardiovascular disease: Amar... http://twurl.nl/gx4uxx
Advertisement
